2020;318(1):H72-H77
78 These DAMPs play a major role in promoting neutrophil infiltration by activating antigen-presenting cells, including Kupffer cells and dendritic cells, which amplifies the immune response and the progression of liver injury
10 The 505(b)(2) pathway provides a regulatory route to overcome technical hurdles including stability, palatability, and manufacturing consistency, allowing firms to focus on improving drug performance rather than starting from zero. FDA 505(b)(2) Trend Analysis, 2025 14 The goal here is Defensive Innovation. By creating a differentiated productperhaps an oral liquid for patients with dysphagia or a longer-acting injectablea firm can bypass the innovators patents while offering a value story that payers will actually reimburse
Next problem, these values are never constant between manufacturing batches, and they will change based on market availability, hence, last batch high performer can be next batch worst performer
10.3390/antiox10060947 14 AnwarM
Bilirubin is a fat-soluble compound which has to be transported attached to albumin on a high-affinity binding site (1:1) within the circulation to the sinusoids of the liver
